Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β

Journal of Molecular Neuroscience : MN
Shengquan HuYifan Han

Abstract

Indirubin-3-oxime (I3O), a synthetic derivative of indirubin, was originally designed as potent inhibitors of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3β (GSK3β) for leukemia therapy. In the current study, we have shown, for the first time, that I3O prevented 6-hydroxydopamine (6OHDA)-induced neuronal apoptosis and intracellular reactive oxygen species accumulation in PC12 cells in a concentration-dependent manner. GSK3β inhibitors but not CDK5 inhibitors reduced the neurotoxicity induced by 6OHDA. Moreover, the activation of GSK3β was observed after 6OHDA treatment. Furthermore, 6OHDA substantially decreased the transcriptional activity of myocyte enhancer factor 2D (MEF2D), a transcription factor that plays an important role in dopaminergic neuron survival, and reduced nuclear localized MEF2D expression. Interestingly, indirubin-3-oxime and GSK3β inhibitors prevented 6OHDA-induced dysregulation of MEF2D. In addition, short hairpin RNA-mediated decrease of MEF2D expression significantly abolished the neuroprotective effects of indirubin-3-oxime. Collectively, our results strongly suggested that indirubin-3-oxime prevented 6OHDA-induced neurotoxicity via activating MEF2D, possibly through the inhibition of G...Continue Reading

References

Mar 20, 2004·Nature Reviews. Drug Discovery·Kevin J BarnhamAshley I Bush
Jun 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiao-Dong ChenMarian F Young
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi BovéSerge Przedborski
Jan 13, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Patrice D SmithDavid S Park
Aug 8, 2007·Journal of Neurochemistry·Lana KupershmidtZeev Blumenfeld
Oct 29, 2009·Leukemia & Lymphoma·Amel ChebelMartine Ffrench
Nov 6, 2009·CNS Neuroscience & Therapeutics·Antoni CaminsMercé Pallás
Feb 19, 2010·Apoptosis : an International Journal on Programmed Cell Death·Qian Yang, Zixu Mao
May 25, 2010·Nature Medicine·Jose A ObesoGlenda Halliday
Oct 16, 2010·Neuroscience Letters·Hoon-Ji JungEunjoo H Lee
Nov 9, 2010·Neurochemical Research·Min-Kyoung KimJi-Hoon Kang
Nov 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lingyan ZhangJohn Lew
Nov 14, 2013·Antioxidants & Redox Signaling·Li GaoQian Yang
Jan 8, 2014·CNS Neuroscience & Therapeutics·Wei CuiYi-Fan Han

❮ Previous
Next ❯

Citations

Sep 30, 2020·International Journal of Molecular Sciences·Minjuan WangMelitta Schachner
Dec 14, 2019·Journal of Neuroscience Research·Yu Chen Chang, Jin Young Kim
Feb 3, 2021·Cells·Melinda E SnitowPeter S Klein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.